Biogen Inc (BIIB)
201.68
+8.50
(+4.40%)
USD |
NASDAQ |
Apr 24, 09:48
Biogen Total Assets (Quarterly): 26.84B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 26.84B |
September 30, 2023 | 28.19B |
June 30, 2023 | 25.16B |
March 31, 2023 | 24.60B |
December 31, 2022 | 24.55B |
September 30, 2022 | 24.85B |
June 30, 2022 | 25.08B |
March 31, 2022 | 23.61B |
December 31, 2021 | 23.88B |
September 30, 2021 | 23.81B |
June 30, 2021 | 24.47B |
March 31, 2021 | 23.85B |
December 31, 2020 | 24.62B |
September 30, 2020 | 24.93B |
June 30, 2020 | 25.51B |
March 31, 2020 | 26.12B |
December 31, 2019 | 27.23B |
September 30, 2019 | 27.48B |
June 30, 2019 | 26.29B |
March 31, 2019 | 26.45B |
December 31, 2018 | 25.29B |
September 30, 2018 | 25.49B |
June 30, 2018 | 23.95B |
March 31, 2018 | 26.09B |
December 31, 2017 | 23.65B |
Date | Value |
---|---|
September 30, 2017 | 23.07B |
June 30, 2017 | 21.76B |
March 31, 2017 | 21.20B |
December 31, 2016 | 22.88B |
September 30, 2016 | 22.10B |
June 30, 2016 | 21.51B |
March 31, 2016 | 20.67B |
December 31, 2015 | 19.50B |
September 30, 2015 | 20.73B |
June 30, 2015 | 16.76B |
March 31, 2015 | 15.22B |
December 31, 2014 | 14.31B |
September 30, 2014 | 13.70B |
June 30, 2014 | 12.92B |
March 31, 2014 | 12.23B |
December 31, 2013 | 11.86B |
September 30, 2013 | 11.25B |
June 30, 2013 | 10.84B |
March 31, 2013 | 10.16B |
December 31, 2012 | 10.13B |
September 30, 2012 | 9.631B |
June 30, 2012 | 9.162B |
March 31, 2012 | 9.114B |
December 31, 2011 | 9.050B |
September 30, 2011 | 8.802B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
23.61B
Minimum
Mar 2022
28.19B
Maximum
Sep 2023
25.32B
Average
24.93B
Median
Sep 2020
Total Assets (Quarterly) Benchmarks
Eli Lilly and Co | 64.01B |
Bristol-Myers Squibb Co | 95.16B |
Gilead Sciences Inc | 62.12B |
AbbVie Inc | 134.71B |
Regeneron Pharmaceuticals Inc | 33.08B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 12.05B |
Shareholders Equity (Quarterly) | 14.80B |
Debt to Equity Ratio | 0.4688 |
Current Ratio | 1.997 |
Net Debt Paydown Yield | -0.35% |